Vaccine News and Research

Latest Vaccine News and Research

Latino teens are deputized as health educators to sway the unvaccinated

Latino teens are deputized as health educators to sway the unvaccinated

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

Epidemiological evidence that Alzheimer's and Parkinson's could be caused by viral infections

Epidemiological evidence that Alzheimer's and Parkinson's could be caused by viral infections

Study shows that SARS-CoV-2 infection is associated with an increased risk for maternal morbidity and severe complications

Study shows that SARS-CoV-2 infection is associated with an increased risk for maternal morbidity and severe complications

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

InDevR raises $9 million in series B financing and partners with bioMérieux

InDevR raises $9 million in series B financing and partners with bioMérieux

WHO reports a severe case of avian (bird) flu in Ecuador

WHO reports a severe case of avian (bird) flu in Ecuador

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

WHO to launch council to accelerate the development of TB vaccine

WHO to launch council to accelerate the development of TB vaccine

Study finds fewer cases of MIS-C during omicron wave of the pandemic than delta

Study finds fewer cases of MIS-C during omicron wave of the pandemic than delta

Researchers find that study results converge on a consistent relationship between antibody levels and protection from COVID-19

Researchers find that study results converge on a consistent relationship between antibody levels and protection from COVID-19

Vaccinated women well protected against severe COVID-19 symptoms, complications during pregnancy

Vaccinated women well protected against severe COVID-19 symptoms, complications during pregnancy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.